Enhancement of tumor radiation response by the antivascular agent 5,6- dimethylxanthenone-4-acetic acid

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 4, 1998, Pages 905-908

  Wilson, William R ^a   Li, Alan E ^a   Cowan, David S M ^a   Siim, Bronwyn G ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Antivascular agent; DMXAA; Fractionated radiotherapy; Tirapazamine; Tumor growth delay

Indexed keywords

5,6 DIMETHYLXANTHENONE 4 ACETIC ACID;

ANIMAL EXPERIMENT; BREAST TUMOR; CANCER INHIBITION; CANCER RADIOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION;

ANIMALS; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG ADMINISTRATION SCHEDULE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; MICE; MICE, INBRED C3H; NEOPLASM, RESIDUAL; NEOPLASMS, EXPERIMENTAL; XANTHENES; XANTHONES;

EID: 0031775298     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00358-7     Document Type: Conference Paper

References (15)

1. Rewcastle G.W., Atwell G.J., Zhuang L., et al. Potential antitumor agents. 61. Structure-activity relationships for in vivo colon-38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids. J Med Chem. 34:1991;217-222.
2. Jameson M., Thompson P., Baguley B., et al. Comparative pharmacokinetics and plasma protein binding of the novel anti-cancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans and mice. (abstract) Proc Am Soc Clin Oncol. 16:1997;213a.
3. Cliffe S., Taylor M.L., Rutland M., et al. Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid. Int J Radiat Oncol Biol Phys. 29:1994;373-377.
4. Lash C.J., Li A.E., Rutland M., et al. Enhancement of the antitumour effects of the antivascular agent 5,6-dimethylxanethenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs. Br J Cancer. 78:1998;439-445.
5. Zwi L.J., Baguley B.C., Gavin J.B., et al. Correlation between immune and vascular activities of xanthenone acetic acid antitumor agents. Oncol Res. 6:1994;79-85.
6. Philpott M., Baguley B.C., Ching L.-M. Induction of tumour necrosis factor α by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid. Cancer Chemother Pharmacol. 36:1995;143-148.
7. Baguley B.C., Ching L.-M. Immunomodulatory actions of xanthenone anticancer drugs. BioDrugs. 8:1997;119-127.
8. Kerr D.J., Kaye S.B. Flavone acetic acid - Preclinical and clinical activity. Eur J Cancer Clin Oncol. 25:1989;1271-1272.
9. Ching L.-M., Joseph W.R., Crosier K.E., et al. Induction of tumor necrosis factor-α messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488). Cancer Res. 54:1994;870-872.
10. Futami H., Eader L.A., Komschlies K.L., et al. Flavone acetic acid directly induces expression of cytokine genes in mouse splenic leukocytes but not in human peripheral blood leukocytes. Cancer Res. 51:1991;6596-6602.
11. Philpott M., Joseph W.R., Crosier K.E., et al. Production of tumour necrosis factor-α by cultured human peripheral blood leucocytes in response to the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488). Br J Cancer. 76:1997;1586-1591.
12. Gridley D.S., Archambeau J.O., Andres M.A., et al. Tumour necrosis factor-a enhances antitumor effects of radiation against glioma xenografts. Oncol Res. 9:1997;217-227.
13. Hallahan D.E., Spriggs D.R., Beckett M.A., et al. Increased tumor necrosis factor mRNA production following cellular exposure to ionising radiation. Proc Natl Acad Sci U S A. 88:1989;10104-10107.
14. Vincent P.W., Roberts B.J., Elliot W.L., et al. Chemotherapy with DMXAA (5,6-dimethylxanthenone-4-acetic acid) in combination with CI-1010 (1H-imidazole-1-ethanol,alpha-[[(2-bromoethyl)amino]methyl]-2-nitro-, mono hydrobromide (R isomer)) against advanced stage murine colon carcinoma 26. Oncol Rep. 4:1997;143-147.
15. Cullen B.M., Walker H.C. The effect of several anaesthetics on the blood pressure and heart rate of the mouse and on the radiation response of the mouse sarcoma RIF-1. Int J Radiat Biol Phys. 48:1985;761-771.